# Filing Detail

Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0001493152-23-039417
Filing Date
2023-11-06
Accepted
2023-11-06 09:09:12
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdefc14a.htm | DEFC14A | 704096
2 |  | formprec14a_001.jpg | GRAPHIC | 3953
3 |  | proxy_001.jpg | GRAPHIC | 329066
4 |  | proxy_002.jpg | GRAPHIC | 431577
| Complete submission text file | 0001493152-23-039417.txt |  | 1759155

Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filed by) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: FL | Fiscal Year End: 1231
Type: DEFC14A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Subject) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: FL | Fiscal Year End: 1231
Type: DEFC14A | Act: 34 | File No.: 001-27072 | Film No.: 231378629
SIC: 2836 Biological Products, (No Diagnostic Substances)